|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
06.01.26 - 12:06
|
AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability (Business Wire)
|
|
|
Med Tech segment delivers fifth consecutive quarter of double-digit growth
Strong adjusted EBITDA; and positive cash flow
Three regulatory milestones support Mechanical Thrombectomy portfolio: Modified AlphaVac 510(k) clearance, PAVE and APEX-Return IDE approvals
Raised full year FY 2026 guidance for net sales and Adjusted EBITDA
Jim Clemmer to retire during fiscal year 2027 as President and CEO upon appointment of successor; Board initiates comprehensive CEO search
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the second quarter of fiscal year 2026, which ended November 30, 2025.
Fiscal Year 2026 Second Quarter Highlights
Quarter Ended
November 30, 2025
Pro Forma* YoY Growth
Net Sales
$79.4 million
8.8%
Med Tech Net Sales
$35.7...
|
|
|
|
|
|
|
|
|
|
|
|
|
23.12.25 - 14:06
|
AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026 (Business Wire)
|
|
|
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it will report financial results for the second quarter of fiscal year 2026 before the market open on Tuesday, January 6, 2026. The Company's management will host a conference call at 8:00 am ET the same day to discuss the results.
To participate in the conference call, dial 1-877-407-0784 (domestic) or +1-201-689-8560 (international). This conference call will also be webcast and can be accessed from the “Investors” section of the AngioDynamics website at www.angiodynamics.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.
A recording of the call will also be available, until Tuesday, January 13, 2026 at 11:59 PM ET. To hear this recording, dial ...
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
